Clinical Trial Update: Adherence Monitoring System in Managing Myelosuppression in Patients With Newly Diagnosed Malignant Gliomas Receiving Temozolomide and Radiation Therapy

View source ↗

Summary

A clinical trial update indicates that the adherence monitoring system trial to manage myelosuppression in newly diagnosed malignant glioma patients receiving t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Malignant Glioma, Myelosuppression | Status: TERMINATED